• Tanezumab ELISA Kit
1 1

AntibodySystem

KDB91701

Tanezumab ELISA Kit

Tanezumab ELISA Kit

Title

Catalog No.: KDB91701

Catalog No. KDB91701
Product name Tanezumab ELISA Kit
Size 96 T
Description PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human NGF has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Tanezumab in the sample competitively binds to the pre-coated protein with biotin-labeled Tanezumab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Tanezumab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications Used for the quantitative determination of Tanezumab concentration in serum and plasma.
Stability and Storage When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20 ℃, the rest reagents should be store at 4℃.
Detection method Colorimetric
Precision CV<20%
Sample type Plasma, Serum
Assay type Quantitative
Sensitivity 128.01 ng/mL
Range 156.25 - 10,000 ng/mL
Recovery 80-120%
Background Tanezumab (RN624) is a recombinant humanized anti- nerve growth factor (NGF) monoclonal antibody (IgG2 type) that works by inhibiting the binding of NGF to its receptors. It was developed by Pfizer as a treatment for pain.
Alternative Names PF-04383119, RN624, CAS: 880266-57-9
Shipping 2-8 ℃
Note For Research Use Only.
전체 세부 정보 보기